Form 4 for AMGN Amgen
Accepted 2022-08-12 00:00:00 ET · period of report 2022-08-10 · accession 0001127602-22-020890 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-12 | 2022-08-10 | AMGN | ECKERT ROBERT | Dir | F - Tax | $252.09 | -6,791 | 27.8K | -20% | -$1.71M |
| D | 2022-08-12 | 2022-08-10 | AMGN | ECKERT ROBERT | Dir | M - OptEx | $85.59 | +20.0K | 34.6K | +137% | +$1.71M |
| D | 2022-08-12 | 2022-08-10 | AMGN | ECKERT ROBERT | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-10 | F | D | 6,791 | $252.09 | 27,784 | D | — | — | (F1) Non-market exercise of a total of 20,000 stock options expiring January 28, 2023 wherein 6,791 shares, in the aggregate, issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price with the remaining shares delivered to the reporting person. (F2) These shares include 2,008 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. |
| 2 | Common | Common Stock | 2022-08-10 | M | A | 20,000 | $85.59 | 34,575 | D | — | — | |
| 3 | Derivative | Nqso (Right to Buy) | 2022-08-10 | M | D | 20,000 | $0.00 | 0 | D | $85.59 · 2014-01-28 to 2023-01-28 | 20,000 Common Stock |